Events Partner Content 5th International Cannabinoid-Derived Pharmaceuticals Summit Unlock the Pharmaceutical Potential of Cannabinoids
News Moderna's RSV shot gets US nod for use in younger adults The label for Moderna's RSV vaccine mResvia has been expanded to include adults aged 18 and over in the US, but will that lead to an uptick in sales?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
